Ernesto Marcos Lopez
Overview
Explore the profile of Ernesto Marcos Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Tilbeurgh M, Lemdani K, Beignon A, Chapon C, Tchitchek N, Cheraitia L, et al.
Vaccines (Basel)
. 2021 Jul;
9(6).
PMID: 34205932
Vaccines represent one of the major advances of modern medicine. Despite the many successes of vaccination, continuous efforts to design new vaccines are needed to fight "old" pandemics, such as...
2.
Leite Pereira A, Jouhault Q, Marcos Lopez E, Cosma A, Lambotte O, Le Grand R, et al.
Front Immunol
. 2020 Oct;
11:2096.
PMID: 33013882
Viral vectors are increasingly used as delivery means to induce a specific immunity in humans and animals. However, they also impact the immune system, and it depends on the given...
3.
Leite Pereira A, Bitoun S, Paoletti A, Nocturne G, Marcos Lopez E, Cosma A, et al.
Front Immunol
. 2019 Nov;
10:2384.
PMID: 31681279
Rheumatoid arthritis (RA) is the most common autoimmune rheumatic disease and leads to persistent chronic inflammation. The pathophysiology of the disease is complex, involving both adaptive and innate immunity. Among...
4.
Leite Pereira A, Tchitchek N, Marcos Lopez E, Lambotte O, Le Grand R, Cosma A
Cytokine
. 2018 Aug;
111:97-105.
PMID: 30138900
HIV infection is associated with chronic inflammation in both non-treated and treated patients. TLR-dependent mechanisms are strongly involved in the maintenance of this inflammation. Indeed, the residual replication of HIV,...
5.
Lazo Vazquez L, Suzarte Portal E, Castro Velazco J, Yen P, Dung L, Gil Gonzalez L, et al.
Clin Transl Immunology
. 2017 Apr;
6(3):e135.
PMID: 28435678
One of the major problems faced for the development of a vaccine against Dengue virus is the lack of a suitable animal model. Although non-human primates do not show overt...
6.
Lazo Vazquez L, Gil Gonzalez L, Marcos Lopez E, Perez Fuentes Y, Cervetto de Armas L, Brown Richards E, et al.
Viral Immunol
. 2017 Apr;
30(5):350-358.
PMID: 28418786
Our group has developed a subunit vaccine candidate against Dengue virus (DENV) based on two different viral regions, the domain III of the envelope protein and the capsid protein. The...